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Abstract 26 
Membrane proteins execute a wide variety of critical biological functions in all living 27 
organisms and constitute approximately half of current targets for drug discovery. As 28 
in the case of soluble proteins, the bacterium Escherichia coli has served as a very 29 
popular overexpression host for biochemical/structural studies of membrane proteins 30 
as well. Bacterial recombinant membrane proteins production, however, is typically 31 
hampered by poor cellular accumulation and severe toxicity for the host, which leads 32 
to low levels of final biomass and minute volumetric yields. In previous work, we 33 
generated the engineered E. coli strains SuptoxD and SuptoxR, which upon co-34 
expression of the effector genes djlA or rraA, respectively, can suppress the cytotoxicity 35 
caused by membrane protein overexpression and produce enhanced membrane protein 36 
yields. Here, we systematically looked for gene overexpression and culturing 37 
conditions that maximize the accumulation of membrane-integrated and well-folded 38 
recombinant MPs in these strains. We have found that, under optimal conditions, 39 
SuptoxD and SuptoxR achieve greatly enhanced recombinant membrane protein 40 
production for a variety of membrane proteins, irrespective of their archaeal, eubacterial 41 
or eukaryotic origin. Furthermore, we demonstrate that the use of these engineered 42 
strains enables the production of well-folded recombinant MPs of high quality and at 43 
high yields, which are suitable for functional and structural studies. We anticipate that 44 
SuptoxD and SuptoxR will become broadly utilized expression hosts for recombinant 45 
membrane protein production in bacteria. 46 
 47 
 48 
 49 
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Membrane proteins (MPs) play key functional roles in all living organisms1 and hold a 57 
prominent position among current targets for drug discovery2. As they are typically 58 
encountered in their native cells and tissues only at very small quantities, acquiring 59 
sufficient amounts of isolated MPs for biochemical and structural studies relies on their 60 
recombinant production in heterologous hosts, such as bacteria, yeasts, insect cells, 61 
mammalian cells and transgenic animals3.  62 
 As in the case of soluble proteins, the bacterium Escherichia coli has been one 63 
of the most popular overexpression hosts for production of recombinant MPs4, 5. Among 64 
its many advantages, E. coli offer great simplicity, speed and low cost; relatively good 65 
understanding of the cell host’s physiology; numerous tools for genetic manipulation5; 66 
high transformation efficiency coupled with established technologies for engineering 67 
the properties of the target MP6; and ability to be propagated in chemically defined 68 
medium allowing for substitution with selenomethionine for X-ray crystal structure 69 
determination7 or with isotopically labeled amino acids for nuclear magnetic resonance 70 
structural studies8.  71 
Bacterial MP production, however, is very often problematic, hampered by poor 72 
cellular accumulation and severe toxicity for the expression host4. MP-induced toxicity 73 
is a very frequent problem associated with recombinant MP production and it often 74 
leads to complete growth arrest, low levels of final biomass, and minute volumetric 75 
protein yields9-11. These unwanted phenomena occur most frequently for proteins of 76 
eukaryotic origin, which are also the ones of highest interest as targets for drug 77 
discovery.   78 
 In our previous work, we showed that we can engineer the bacterial protein 79 
synthesis machinery so as to generate modified E. coli strains with the ability to 80 
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withstand the toxicity caused by MP overexpression12. This allowed the development 81 
of specialized E. coli strains, which can be generally utilized for high-level recombinant 82 
MP production12. In order to achieve this, we sought single bacterial genes, whose co-83 
expression can suppress MP overexpression-induced toxicity. After carrying out a 84 
genome-wide screen, we identified two highly potent suppressors: (i) djlA, the gene 85 
encoding for the membrane-bound DnaK co-chaperone DjlA13, and (ii) rraA, the gene 86 
encoding for RraA, an inhibitor of the mRNA-degrading activity of the E. coli RNase 87 
E14. E. coli strains co-expressing either djlA or rraA, which were named SuptoxD and 88 
SuptoxR, respectively, were found capable of accumulating significantly higher levels 89 
of final biomass and of producing dramatically enhanced yields for a variety of 90 
recombinant MPs in properly membrane-embedded form12, 15.  91 
 In the present work, we systematically looked for gene overexpression and 92 
culturing conditions that maximize the accumulation of membrane-integrated and well-93 
folded recombinant MPs in E. coli SuptoxD and SuptoxR. We report that, under optimal 94 
conditions, SuptoxD and SuptoxR achieve greatly enhanced recombinant membrane 95 
protein production compared to wild-type E. coli, for a variety of both prokaryotic and 96 
eukaryotic MPs. Furthermore, we demonstrate that the use of these engineered strains 97 
enables the production of well-folded recombinant MPs at high quality and yields, 98 
which are suitable for functional and structural studies. Based on these results, we 99 
anticipate that SuptoxD and SuptoxR will become broadly utilized expression hosts for 100 
recombinant MP production in bacteria. 101 
   102 
 103 
 104 
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Results and Discussion 105 
Characteristics of the E. coli strains SuptoxD and SuptoxR. E. coli SuptoxD and 106 
SuptoxR are two specialized strains for achieving high-level recombinant MP 107 
production in bacteria12. Their use has a dual positive effect on recombinant MP 108 
production: (i) it suppresses the toxicity that is frequently associated with MP 109 
overexpression, thus resulting in enhanced levels of final bacterial biomass, and (ii) it 110 
markedly enhances the cellular accumulation of membrane-incorporated and well-111 
folded protein for a variety of recombinant MPs of both prokaryotic and eukaryotic 112 
origin12, 15. The combination of these two positive effects of MP production, results in 113 
greatly enhanced volumetric accumulation of recombinant MPs compared to wild-type 114 
E. coli 12, 15. 115 
 The toxicity-suppressing and cellular production-promoting capabilities of 116 
SuptoxD and SuptoxR are based on the overexpression of either one of the effector 117 
genes djlA or rraA, respectively. In these strains, djlA and rraA are overexpressed from 118 
the vectors pSuptoxD and pSuptoxR, respectively, under the control of the araBAD 119 
promoter and its inducer L(+)-arabinose (Figure 1; Table 1)12. For the production of 120 
recombinant MPs in these strains, we typically use the vector pASK7516 under the 121 
control of a tet promoter and its inducer anhydrotetracycline (aTc) (Figure 1; Table 1), 122 
although the enhanced MP productivity SuptoxD and SuptoxR is not promoter-123 
dependent12, 15.  124 
 125 
 126 
 127 
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 128 
Figure 1. Characteristics of the specialized MP-producing E. coli strains SuptoxD 129 
and SuptoxR. The toxicity-suppressing and cellular production-promoting capabilities 130 
of SuptoxD and SuptoxR are based on the overexpression of either one of the effector 131 
genes djlA or rraA, respectively. djlA and rraA are overexpressed from the vectors 132 
pSuptoxD and pSuptoxR, respectively, under the control of the araBAD promoter and 133 
its inducer L(+)-arabinose. For the production of recombinant MPs in these strains, we 134 
typically use pASK75-based plasmids under the control of a tet promoter and its inducer 135 
aTc (pASK-MP vector). 136 
 137 
Optimization of expression conditions for recombinant MP production in 138 
SuptoxD and SuptoxR. In order to determine optimal conditions for recombinant MP 139 
production in SuptoxD and SuptoxR, we tested a range of different expression 140 
parameters and looked for combinations that maximize volumetric accumulation of 141 
membrane-integrated and folded MP. For fast expression monitoring, we utilized C-142 
terminal MP fusions with the green fluorescent protein (GFP) and recorded the levels 143 
of cellular MP-GFP fluorescence corresponding to equal culture volumes (volumetric 144 
accumulation) for each condition. This choice was based on the fact that the 145 
fluorescence of E. coli cells expressing MP-GFP fusions has previously been found to 146 
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correlate well with the amount of membrane-integrated recombinant MP17 and has been 147 
used extensively for facile monitoring of the accumulation levels of membrane-148 
incorporated recombinant MPs, for optimization of overexpression parameters and for 149 
strain development, by us12, 15, 18-20 and many others groups21-26. 150 
 We first evaluated the effect of varying the expression levels of the effector gene 151 
djlA in SuptoxD by changing the concentration of the inducer L(+)-arabinose in the 152 
growth medium. Arabinose concentrations in the range 0.0025-0.02% yielded maximal 153 
increases in volumetric cellular MP-GFP fluorescence compared to wild-type E. coli 154 
for two recombinant MPs tested: the human bradykinin receptor 2 (BR2) and the D03 155 
variant of the rat neurotensin receptor 1 (NTR1(D03))6 (Table 1; Figures. 2a and b). 156 
Both MPs are members of the G protein-coupled receptor (GPCR) superfamily and are 157 
of high interest as targets for drug discovery27, 28. The three-dimensional structure of 158 
NTR1 has been solved recently27, while the structure of BR2 remains undetermined. 159 
Arabinose concentrations higher than 0.02% did not result in higher MP productivity, 160 
presumably due to the toxicity that is associated with strong djlA overexpression13, 29. 161 
Western blot and in-gel fluorescence analyses30 of isolated total membrane fractions of 162 
wild type and SuptoxD cells producing NTR1(D03)-GFP verified that the enhanced 163 
MP-GFP fluorescence phenotypes observed occur due to increased production of full-164 
length, membrane-embedded and well-folded recombinant MP (Figure 2c). Thus, 165 
addition of 0.0025-0.02% arabinose results in high-level production of recombinant 166 
MPs in E. coli SuptoxD, with an apparent optimum at 0.01%. 167 
  We next performed a similar analysis for the effector gene rraA in SuptoxR 168 
using again two model MPs: BR2 and the large conductance mechanosensitive ion 169 
channel (MscL) from Mycobacterium tuberculosis (Table 1). In this case, higher arabi- 170 
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 (a)                                                          (b)                                              171 
172 
(c) 173 
 174 
Figure 2. Determination of the optimal levels of djlA co-expression for maximal 175 
recombinant MP production in E. coli SuptoxD cells by arabinose titration. (a). 176 
Fluorescence of equal culture volumes of E. coli MC1061 (Wild type) and SuptoxD 177 
cells producing BR2-GFP by the addition of 0.2 μg/ml aTc and the indicated arabinose 178 
concentrations for 16 h at 25 °C. The fluorescence of BR2-producing MC1061 cells 179 
was arbitrarily set to one. (b). For NTR1(D03)-GFP as in (a). (c). Sodium dodecyl 180 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)/western blot analysis of 181 
isolated total membrane fractions of equal culture volumes of MC1061 (Wild type, WT) 182 
and SuptoxD cells producing NTR1(D03)-GFP as described in (b), visualization of the 183 
produced fusion by in-gel fluorescence and western blotting using a C-terminal anti-184 
polyhistidine or a N-terminal anti-FLAG antibody without (non-boiled) or with boiling 185 
(boiled) of the samples prior to loading as indicated. The black and white arrows 186 
indicate the positions of the fluorescent and non-fluorescent NTR1(D03)-GFP bands, 187 
respectively. In (a) and (b), experiments were carried out in replica triplicates and the 188 
error bars represent one standard deviation from the mean value.    189 
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(a)                                                            (b) 190 
  191 
(c)                                   192 
 193 
Figure 3. Determination of the optimal levels of rraA co-expression for maximal 194 
recombinant MP production in E. coli SuptoxR cells by arabinose titration. (a). 195 
Fluorescence of equal culture volumes of E. coli MC1061 (Wild type) and SuptoxR 196 
cells producing BR2-GFP by the addition of 0.2 μg/ml aTc and the indicated arabinose 197 
concentrations for 16 h at 25 °C. The fluorescence of BR2-producing MC1061 cells 198 
was arbitrarily set to one. Experiments were carried out in replica triplicates and the 199 
error bars represent one standard deviation from the mean value. (b). For MscL-GFP 200 
as in (a). Mean values ± s.d. are presented (n=3 independent experiments, each one 201 
performed in replica triplicates). (c). SDS-PAGE/western blot analysis of isolated total 202 
membrane fractions of equal culture volumes of MC1061 (Wild type, WT) and 203 
SuptoxR cells producing MscL-GFP as described in (b), visualization of the produced 204 
fusion by in-gel fluorescence and western blotting using a C-terminal anti-polyhistidine 205 
antibody without (non-boiled) or with (boiled) boiling of the samples prior to loading 206 
as indicated. The black and white arrows indicate the positions of the fluorescent and 207 
non-fluorescent MscL-GFP bands, respectively.    208 
 209 
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nose concentrations in the range 0.01-0.4% were required for maximal recombinant MP 210 
production, with an apparent optimum at 0.2-0.4% (Figure 3). 211 
 Having established optimal cellular levels for DjlA and RraA, we searched for 212 
aTc concentrations that maximize overexpression of recombinant MPs in SuptoxD and 213 
SuptoxR. For both strains, 50-400 μg aTc per L of shake flask culture resulted in the 214 
highest accumulation of membrane-embedded, full-length and well-folded recombinant 215 
MP for all tested targets (Figures 4 and 5). 216 
 The incubation temperature, at which MP production occurs, had a strong 217 
impact on the final volumetric accumulation of recombinant MP for both SuptoxD and 218 
SuptoxR (Figure 6a). This is consistent with what has been observed previously with 219 
other strains and for other recombinant MPs22. Induction of protein production at 25 oC 220 
resulted in maximized productivity of recombinant MP for both SuptoxD and SuptoxR 221 
(Figure 6a).  222 
 Under optimal production conditions (incubation temperature and inducer 223 
concentrations), the volumetric production of recombinant MP increased for both 224 
SuptoxD and SuptoxR until 12-14 h after aTc addition to the medium and leveled-off 225 
after that (Figure 6b). Importantly, even after 16 h continuous production of MPs, 226 
whose strong overexpression is severely toxic for E. coli and typically causes complete 227 
growth arrest following induction, such as BR2 and NTR112, 20, 31, SuptoxD and 228 
SuptoxR cultures were homogeneous as revealed by flow cytometry analysis, thus 229 
demonstrating MP genetic stability in these strains (Figure 6c). 230 
 231 
 232 
12 
 
(a)                                                                 (b)                                                   233 
 234 
(c) 235 
 236 
Figure 4. Optimization of recombinant MP production in E. coli SuptoxD cells by 237 
aTc titration. (a). Fluorescence of equal culture volumes of E. coli MC1061 (Wild 238 
type) and SuptoxD cells producing BR2-GFP by the addition of 0.01% arabinose for 239 
16 h at 25 °C. The fluorescence of BR2-producing MC1061 cells was arbitrarily set to 240 
one. (b). For NTR1(D03)-GFP as in (a). (c). SDS-PAGE/western blot analysis of 241 
isolated total membrane fractions of equal culture volumes of MC1061 (Wild type, WT) 242 
and SuptoxD cells producing NTR1(D03)-GFP as described in (b), visualization of the 243 
produced fusion by in-gel fluorescence and western blotting using a C-terminal anti-244 
polyhistidine or a N-terminal anti-FLAG antibody without (non-boiled) or with boiling 245 
(boiled) of the samples prior to loading as indicated. The black and white arrows 246 
indicate the positions of the fluorescent and non-fluorescent NTR1(D03)-GFP bands, 247 
respectively. In (a) and (b), experiments were carried out in replica triplicates and the 248 
error bars represent one standard deviation from the mean value.    249 
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   (a)                                                                (b) 250 
  251 
(c)    252 
 253 
 254 
Figure 5. Optimization of recombinant MP production in E.coli SuptoxR cells by 255 
aTc titration. (a). Fluorescence of equal culture volumes of E. coli MC1061 (Wild 256 
type) and SuptoxR cells producing BR2-GFP by the addition of 0.2% arabinose for 16 257 
h at 25 °C. The fluorescence of BR2-producing MC1061 cells was arbitrarily set to one. 258 
(b). For MscL-GFP as in (a). (c). SDS-PAGE/western blot analysis of isolated total 259 
membrane fractions of equal culture volumes of MC1061 (wild type, WT) and SuptoxR 260 
cells producing MscL-GFP as described in (b), visualization of the produced fusion by 261 
in-gel fluorescence and western blotting using a C-terminal anti-polyhistidine antibody 262 
without (non-boiled) or with (boiled) boiling of the samples prior to loading as 263 
indicated. The black and white arrows indicate the positions of the fluorescent and non-264 
fluorescent MscL-GFP bands, respectively. In (a) and (b), experiments were carried out 265 
in replica triplicates and the error bars represent one standard deviation from the mean 266 
value.    267 
   268 
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(a)                                                          (b) 269 
 270 
(c) 271 
 272 
Figure 6. Determination of optimal culturing temperature and time for 273 
recombinant MP production in E. coli SuptoxD and SuptoxR. (a). Fluorescence of 274 
E. coli MC1061 (Wild type), SuptoxD and SuptoxR cells producing BR2-GFP by the 275 
addition of 0.2 μg/ml aTc and 0.01% (SuptoxD) or 0.2% (SuptoxR) arabinose at the 276 
indicated temperatures overnight. Mean values ± s.d. are presented (n=3 independent 277 
experiments, each one performed in replica triplicates). The fluorescence of BR2-278 
producing MC1061 cells at 25 oC was arbitrarily set to one. (b). Comparison of the 279 
fluorescence of equal culture volumes of E. coli MC1061 (wild type), SuptoxD and 280 
SuptoxR cells producing BR2-GFP by the addition of 0.2 μg/mL aTc and 0.01% 281 
(SuptoxD) or 0.2% (SuptoxR) arabinose overnight at 25 °C at different time points after 282 
aTc addition to the medium. The fluorescence of BR2-producing MC1061 cells at 16 h 283 
was arbitrarily set to one. Experiments were carried out in replica triplicates and the 284 
error bars represent one standard deviation from the mean value. (c). (Left) Forward 285 
versus side scatter plots as determined by flow cytometry analysis of E. coli MC1061 286 
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(Wild type), SuptoxD and SuptoxR cells producing BR2-GFP or NTR1(D03)-GFP by 287 
the addition of 0.2 μg/mL aTc and 0.01% (SuptoxD) or 0.2% (SuptoxR) arabinose for 288 
16 h at 25 °C. (Right) Comparison of the levels of individual cell fluorescence of E. 289 
coli MC1061 (Wild type), SuptoxD and SuptoxR cells producing BR2-GFP or 290 
NTR1(D03)-GFP(bottom) as measured by flow cytometry. Cells were gated as 291 
indicated by the grey line (left). Fluorescence measurements correspond to the mean 292 
value (M) of replica experiments performed in triplicate.  293 
 294 
SuptoxD and SuptoxR achieve enhanced production of detergent-extractable and 295 
functional recombinant MP. Our results indicate that, under optimal conditions, 296 
SuptoxD and SuptoxR achieve greatly enhanced production of full-length, membrane-297 
embedded and well-folded recombinant MPs compared to wild-type E. coli. In order to 298 
test whether these enhanced amounts contain biologically active protein and, thus, 299 
would be suitable for functional studies, we compared the accumulation of the archaeal 300 
deltarhodopsin from Haloterrigena turkmenica (HtdR) in wild-type E. coli and 301 
SuptoxD/SuptoxR. HtdR is a light-driven outwards proton pump, which when properly 302 
folded, can bind the chromophore all-trans-retinal and acquires a characteristic purple 303 
color with an adsorption maximum at ~550 nm32. Apart from model proteins for 304 
convenient monitoring of functional protein production33, microbial rhodopsins are also 305 
invaluable tools for optogenetic regulation applications30. E. coli has served as a cell 306 
factory for recombinant production of this type of MPs for biochemical and structural 307 
studies34, 35, as well as for the engineering of protein variants with new properties36, 37.  308 
Under optimal MP production conditions, our strains were found to accumulate 309 
significantly enhanced levels of both total and detergent-extractable functional HtdR 310 
(Figure 7).    311 
 312 
 313 
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(a)  314 
 315 
(b) 316 
  317 
Figure 7. SuptoxD and SuptoxR produce enhanced amounts of functional 318 
recombinant MP. (a). Photographs of purple-colored pellets derived from equal 319 
culture volumes of MC1061 (Wild type), SuptoxD and SuptoxR cells producing HtdR 320 
by the addition of 0.2 μg/ mL aTc and 0.01% (SuptoxD) or 0.2% (SuptoxR) arabinose 321 
for 16 h at 25 °C in the presence of 10 μM all-trans-retinal. (b). (Left) Photographs of 322 
DDM-extracted HtdR acquired from the total lysates of equal culture volumes of the 323 
MC1061 (Wild type), SuptoxD and SuptoxR cells shown in (a). (Right) Relative 324 
absorbance at 550 nm of the samples shown in (b), left.  325 
 326 
SuptoxD and SuptoxR achieve greatly enhanced production of purified 327 
recombinant MPs. Structural and biophysical studies of MPs typically require the 328 
availability of mg quantities of detergent-extracted and isolated protein in a folded state. 329 
The required yields of purified protein from an MP-overexpression strain for such 330 
purposes should be in the range 0.2-1 mg per L of cell culture3. To determine the yields 331 
of purified recombinant MPs expressed in our strains, we produced polyhistidine-332 
tagged versions of BR2 in SuptoxD and the MscL variant F88C (see below) in SuptoxR 333 
under the optimal expression conditions determined above. Both MPs were solubilized 334 
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from isolated total membranes in detergent and were purified using immobilized metal 335 
affinity chromatography (IMAC), followed by size-exclusion chromatography (SEC). 336 
BR2 was extracted using fos-choline-14 (Fos14), while MscL using n-dodecyl β-D-337 
maltoside (DDM). For both MPs, we performed control purification experiments from 338 
wild-type E. coli under identical conditions. The yield of isolated BR2 from SuptoxD 339 
was found to be ~1 mg per L of shake flask culture. This is approximately 14-fold 340 
higher than the corresponding yield from wild-type E. coli (~47.4 mAU absorption for 341 
SuptoxD compared to ~3.5 mAU for wild type) (Figure 8a). BR2 isolated from 342 
SuptoxD eluted as a single peak in SEC, indicating that purified protein in DDM 343 
solution is  folded and non-aggregated (Figure 8a). 344 
 345 
Figure 8. E. coli SuptoxD produce greatly enhanced amounts of isolated 346 
recombinant MP. (a). SEC profiles of purified BR2 from E. coli MC1061 (Wild type; 347 
black) and SuptoxD (red) (b). SDS-PAGE analysis of the BR2 SEC peaks (~67 mL on 348 
a Superdex200 16/60 GE column) obtained in (a). MWM: molecular weight marker. 349 
The numbers indicate the corresponding molecular masses in kDa. 350 
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The purity of the SEC peaks of the isolated BR2 was assessed by SDS-PAGE analysis. 352 
This revealed adequate sample purity for initial screening and characterization purposes 353 
(Figure 8b). The strong single band appearing after BR2 purification from SuptoxD 354 
exhibited the expected electrophoretic mobility corresponding to apparent molecular 355 
mass of ~35 kDa (detergent-extracted BR2 and other MPs run faster on SDS-PAGE 356 
than expected according to their molecular weight31, 38) and its identity was confirmed 357 
by western blot analysis and mass spectrometry following trypsin digestion 358 
(Supplementary Figure S1). It is important to note, that human BR2 is a particularly 359 
challenging MP to produce recombinantly, not only in microbial expression hosts31 but 360 
also in human cell cultures38.  361 
 362 
Figure 9. E. coli SuptoxR produce greatly enhanced amounts of isolated 363 
recombinant MP. (a). SEC profiles of purified MscL from E. coli MC1061 (Wild type; 364 
black) and SuptoxR (red), revealing a single homogeneous monodisperse peak of MscL 365 
pentamers. (b). SDS-PAGE analysis of the pentameric MscL(F88C) SEC peaks 366 
obtained from (a). The gel indicates the presence of highly pure protein containing only 367 
MscL(F88C) monomers and disulfide-linked dimers. F88C is located at the interface of 368 
two neighboring subunits and the appearance of reducing agent-resistant disulfide-369 
linked dimers is in agreement with previous studies of single cysteine mutants of both 370 
E. coli MscL and the small conductance mechanosensitive ion channel (MscS)39, 40. 371 
MWM: molecular weight marker. The numbers indicate the corresponding molecular 372 
masses in kDa. 373 
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 374 
Figure 10. E. coli SuptoxR produce well-folded MP at the expected 375 
oligomerization and conformational state. (a). Side and top MscL channel pore view. 376 
F88C is highlighted (cyan spheres). Pentameric MscL is labelled with five spin labels 377 
resulting in pentagon symmetry and thus two expected distances in PELDOR/DEER. 378 
(b). Raw, uncorrected time domain spectrum (black) with the background function 379 
(red). (c). Background corrected time domain spectrum (black) with the fitting function 380 
(red). (d). PELDOR distance distribution of MscL(F88C) covalently modified with 381 
MTSSL (blue area, corresponding to mean ±2σ confidence interval as calculated by the 382 
DeerAnalysis validation tool) compared to in silico-modelled distances (red) of the 383 
MscL crystal structure (PDB 2OAR), using MtsslWizard. The rainbow colour bar 384 
indicates the reliability of the distance range (calculated by DeerAnalysis), based on the 385 
experimental 4 μs time window used. 386 
 387 
 Similarly to the results acquired with SuptoxD, a >10-fold increased yield was 388 
observed for the purified mechanosensitive ion channel MscL in SuptoxR compared to 389 
wild-type E. coli (~5.40 mAU absorption for SuptoxD compared to ~0.47 for wild-390 
type) (Figure 9a). The yields of purified MscL were calculated to be ~0.33 mg and 0.03 391 
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mg per L of shake flask culture for SuptoxR and wild-type E. coli, respectively. The 392 
recorded SEC peak for SuptoxR-purified MscL was monodisperse and highly 393 
homogeneous and eluted at ~69 mL from a Superdex200 16/60 column, thus indicating 394 
a highly monodisperse and well-folded multimeric channel protein. The purity of these 395 
SEC peaks was further assessed by SDS-PAGE (Figure 9b) and the identity of the MscL 396 
bands was confirmed by mass spectrometry (Supplementary Figure S2). 397 
 In order to assess whether the SuptoxR-produced MscL is well folded and so as 398 
to determine its oligomeric and conformational state in DDM solution, we combined 399 
pulsed electron electron double resonance (PELDOR) (also known as double electron 400 
electron resonance (DEER)) spectroscopy with site-directed spin labelling41-43. This 401 
method allows for measurement of interspin distances of engineered/introduced 402 
paramagnetic species (carrying unpaired electrons) within protein complexes between 403 
1.5 to 7 nm and irrespective of their size. PELDOR has served as a powerful tool for 404 
studying conformation, oligomeric state and complex dynamics of various MP types, 405 
such as ion channels, transporters and GPCRs39, 44-49, at molecular resolution and in 406 
complete agreement with X-ray crystallography studies50. To perform PELDOR 407 
analysis of MscL, we introduced the S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-408 
yl)methyl methanesulfonothioate (MTSSL) spin label by covalent attachment to the 409 
single-cysteine variant MscL (F88C), resulting in a MscL pentamer carrying five spins 410 
per macromolecule (Figure 10a). Due to the expected pentagon symmetry, two distinct 411 
distances, i.e. D1 and D2, are anticipated (Figure 10a), thus allowing the determination 412 
of the oligomerization and conformational state of the purified MscL in detergent 413 
solution. We obtained a PELDOR time trace with clear dipolar oscillations in the raw 414 
data and a 4-μs time window (Figure 10b), which allowed accurate distances to be 415 
determined, after background correction (Figures 10c and d). The resulting distance 416 
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distribution was in very good agreement with the in silico modelled distances of the 417 
closed state pentameric MscL (PDB 2OAR)51, suggesting that the SuptoxR-produced 418 
MscL channel is correctly folded and adopts a symmetric pentameric arrangement in 419 
the closed conformation. The pentameric state of the SuptoxR-isolated MscL was 420 
further confirmed by the resulting distance peak ratio D2/D1 ~1.6 (for a perfectly 421 
symmetric pentamer this ratio is 1.641). PELDOR/DEER, therefore, provides robust 422 
experimental evidence for the correct folding and structural integrity of the MscL 423 
channel protein produced in SuptoxR.   424 
 Overall, our results demonstrate that E. coli SuptoxD and SuptoxR are two 425 
specialized strains that achieve greatly enhanced recombinant MP production in 426 
bacteria. In our present and previous work12, 15 we have found that this enhanced 427 
productivity occurs for membrane proteins (1) from all three domains of life (archaeal, 428 
eubacterial and eukaryotic); (2) with different functions (GPCR, mechanosensitive 429 
channel, light-driven proton pump proton pump and other); and (3) with different 430 
molecular and topological characteristics (size, number of transmembrane helices, 431 
oligomerization states etc.). Under the optimized production conditions determined 432 
here, the use of these strains allows the production of high-quality recombinant MPs at 433 
quantities sufficient for functional and structural studies. Recombinant MP production 434 
in these strains yields well-folded and homogeneous proteins, which maintain their 435 
structural integrity. Based on these results, we anticipate that SuptoxD and SuptoxR 436 
will become broadly utilized expression hosts for recombinant MP production in 437 
bacteria. 438 
 439 
 440 
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Methods  441 
Plasmid construction. All enzymes for cloning of recombinant DNA were purchased 442 
from New England Biolabs. The plasmid pASKMscL-EGFP was generated by 443 
amplifying the sequence encoding the gene mscL by PCR from the vector 444 
pJ411TbMscL (DNA 2.0), with the primers MscLwtM.tuberculosisFOR (5’ 445 
AAAAATCTAGAAGGAGGAAACGATGTTGAAAGGCTTTAAAG-3’) and 446 
MscLwtM.tuberculosisREV (5’-AAAAAGGATCCCTCGAGCTGGCTTTCGGTAG-447 
3’), digesting with XbaI and BamHI, and by cloning the resulting fragment into the 448 
similarly digested vector pASKBR2-EGFP in place of the BR2-encoding gene. The 449 
plasmid pASKHtdR was generated by amplification of the htdR gene from pHtdR200 450 
[12] with the htdR-specific DNA primers HtdRFOR (5’-451 
AAAAAATCTAGAAGGAGGAAACGATGTGTTACGCTGCTCTAGCACC-3’) 452 
and HtdRREV (5’-453 
AAAAAAAGCTTTTAGTGGTGATGGTGGTGATGGGTCGGGGCAGCCGTCGG454 
CG-3’) carrying XbaI and HindIII recognition sequences, digestion with XbaI and 455 
HindIII, and ligation into similarly digested pASK75. The plasmid pASKMscL(F88C) 456 
was generated by amplifying the gene encoding MscL(F88C) by PCR from the vector 457 
pJ411TbMscL(F88C) (DNA 2.0) with the primers MscLwtM.tuberculosisFOR (5’-458 
AAAAATCTAGAAGGAGGAAACGATGTTGAAAGGCTTTAAAG-3’) and 459 
MscLwtM.tuberculosisREVHISTAG (5’-460 
AAAAAAAGCTTTTAGTGGTGATGGTGGTGATGCTCGAGCTGG-3’), digesting 461 
with XbaI and HindIII, and by cloning the resulting fragment into the similarly digested 462 
vector pASK75. 463 
23 
 
MP overexpression in liquid cultures. E. coli cells freshly transformed with the 464 
appropriate expression vector(s) were used for all protein production experiments. 465 
Single bacterial colonies were used to inoculate liquid LB cultures containing the 466 
appropriate combination of antibiotics (100 μg/mL ampicillin, 40 μg/mL 467 
chloramphenicol or 50 μg/mL kanamycin (Sigma)). These cultures were used with a 468 
1:50 dilution to inoculate fresh LB cultures with 0.01% (MC1061 and SuptoxD) or 469 
0.2% arabinose (SuptoxR), which were grown at 30 °C to an optical density at 600 nm 470 
(OD600) of ∼0.3−0.5 with shaking, unless specified otherwise. The temperature was 471 
then decreased to 25 °C and after a temperature equilibration period of 10−20 min, MP 472 
expression was induced by the addition of 0.2 μg/mL aTc (Sigma) overnight, unless 473 
specified otherwise. For rhodopsin overproduction, we followed the same procedure, 474 
but when the cell density reached OD600 ∼0.3−0.5, protein production was induced by 475 
the addition of 0.2 μg/mL aTc in the presence of 10 μM all-trans-retinal (Cayman 476 
Chemical) overnight in dark. 477 
Membrane isolation. Total membrane fractions were isolated from 1 L LB cultures in 478 
all cases, except for rhodopsin (250 mL). Cells were harvested by centrifugation (4,000 479 
x g for 10 min) and resuspended in 10 mL of cold lysis buffer (300 mM NaCl, 50 mM 480 
NaH2PO4, 15% glycerol, 5 mM dithiothreitol, pH 7.5). The cells were lysed by brief 481 
sonication steps on ice and the resulting lysates were clarified by centrifugation at 482 
10,000 x g for 15 min. The supernatant was then subjected to ultracentrifugation on a 483 
Beckman 70Ti rotor at 42,000 rpm (130,000 x g) for 1 h at 4 °C. The resulting pellet 484 
was finally re-suspended in 5 mL of cold lysis buffer and homogenized.  485 
Western blot and in-gel fluorescence analyses. Proteins samples were analyzed by 486 
sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS−PAGE) in 12-15% 487 
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gels with or without prior boiling of the samples for 10 min for western blotting and 488 
without prior boiling for in-gel fluorescence analysis. In-gel fluorescence was analyzed 489 
on a UVP ChemiDoc-It2 Imaging System equipped with a CCD camera and a GFP 490 
filter, after exposure for about 3 s. For western blotting, proteins were transferred to 491 
polyvinylidene fluoride (PVDF) membranes (Merck) for 45 min at 12 V on a semidry 492 
blotter (Thermo Scientific). Membranes were blocked with 5% nonfat dried milk in 493 
Tris- buffered saline containing 0.1% Tween-20 (TBST) for 1 h at room temperature. 494 
After washing with TBST three times, membranes were incubated with the appropriate 495 
antibody dilution in TBST containing 0.5% nonfat dried milk at room temperature for 496 
1 h. The utilized antibodies were a mouse monoclonal antipolyhistidine antibody 497 
(Sigma) at 1:3,000 dilution (conjugated with horseradish peroxidase), a mouse 498 
monoclonal anti-FLAG antibody (Sigma) at 1:1,000 dilution, with a horseradish 499 
peroxidase-conjugated goat anti-mouse as secondary antibody at 1:5,000 dilution. The 500 
proteins were visualized using a ChemiDoc-It2 Imaging System (UVP). 501 
Bulk fluorescence measurements. Cells corresponding to 0.5 mL of culture were 502 
harvested and resuspended in 100 μL PBS. The cell suspension was then transferred to 503 
a black 96-well plate and after fluorophore excitation at 488 nm, fluorescence was 504 
measured at 510 nm using a TECAN SAFIRE plate reader.  505 
Fluorescence analysis by flow cytometry. ~107 cells were re-suspended in 1 mL PBS 506 
and after fluorophore excitation at 488 nm, the fluorescence of 50,000 cells was 507 
measured at 530/30 nm using a CyFlow ML flow cytometer (Partec) and analyzed 508 
statistically using FlowJo 7.6.2.  509 
Rhodopsin extraction and quantification. Pellets from 250 mL of cell culture were 510 
re-suspended in 7.5 ml cold lysis buffer. Cells were lysed by brief sonication steps on 511 
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ice and rhodopsin was extracted from total cell lysates by the addition of 2.5% (w/v) 512 
DDM (Glycon Biochemicals) and rotation at 180 rpm for 24 h at 4 oC in the dark. Τhe 513 
mixture was subjected to  ultra-centrifugation and, if a colorless pellet was acquired, 514 
the supernatant (detergent-extractable fraction) was collected analyzed by measuring 515 
absorbance at 550 nm as described previously32, 52. 516 
MscL and BR2 purification. MscL(F88C) was expressed in E. coli MC161 (wild type) 517 
and SuptoxR, spin labelled and purified as previously described41, 48. The extent of 518 
cysteine modification (i.e. spin labelling efficiency) was assessed as previously 519 
described 53. In brief, protein pellets were resuspended in phosphate-buffered saline 520 
(PBS), lysed with a cell disrupter at 30,000 psi and centrifuged at 4,000 x g for 20 min. 521 
The supernatant was then ultra-centrifuged at 100,000 x g for 1 h. The resulting 522 
membrane pellet was mechanically resuspended in solubilisation buffer (50 mM 523 
sodium phosphate of pH 7.5, 300 mM NaCl, 10% v/v glycerol, 50 mM imidazole, 1.5% 524 
w/v DDM (Glycon, GmbH) and incubated at 4 oC for 1 h. The sample was then 525 
centrifuged at 4,000 x g for 10 min and the supernatant was passed through a column 526 
containing 0.5 mL Ni2+-nitrilotriacetic acid (Ni2+-NTA) beads (Sigma). Subsequently, 527 
the column was washed with 10 mL wash buffer (50 mM sodium phosphate pH 7.5, 528 
300 mM NaCl, 10% v/v glycerol, 50 mM imidazole, 0.05% w/v DDM) and 5 mL wash 529 
buffer supplemented with 3 mM tris(2-carboxyethyl)phosphine (TCEP). Then, MTSSL 530 
(Glycon) dissolved in wash buffer at 10x excess of the expected protein concentration 531 
was added to the column and left to react for 2 h at 4 oC. The protein was then eluted 532 
with 5 mL of elution buffer (50 mM sodium phosphate of pH 7.5, 300 mM NaCl, 10% 533 
v/v glycerol, 300 mM imidazole, 0.05% w/v DDM) before being subjected to SEC 534 
using a Superdex 200 column (GE Healthcare) equilibrated with SEC buffer (50 mM 535 
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sodium phosphate of pH 7.5, 300 mM NaCl, 0.05% w/v DDM). Finally, the protein 536 
was concentrated to ~800 µM monomer concentration for PELDOR measurements. 537 
 The purification protocol used for BR2 from E. coli MC161 (wild type) and 538 
SuptoxD was similar, with the exception that different buffers were used: solubilisation 539 
buffer (10 mM HEPES of pH 7.2, 400 mM NaCl, 10% v/v glycerol, 30 mM imidazole, 540 
0.5% w/v fos-14 (Anatrace) wash buffer (10 mM HEPES of pH 7.2, 400 mM NaCl, 541 
10% v/v glycerol, 30 mM imidazole, 0.05% w/v DDM); elution buffer (10 mM HEPES 542 
of pH 7.2, 400 mM NaCl, 10% v/v glycerol, 300 mM imidazole, 0.05% w/v DDM); 543 
and SEC buffer (10 mM HEPES of pH 7.2, 400 mM NaCl, 0.05% w/v DDM).  544 
PELDOR measurements, data analysis and in silico spin labelling and distance 545 
modelling. Purified MscL(F88C) was mixed at a 1:1 ratio with deuterated ethylene 546 
glycol and 70 µL of the mixture were loaded in a 3 mm quartz tube and flash frozen in 547 
liquid N2. PELDOR measurements were performed with a Bruker ELEXSYS E580 548 
pulsed Q band (34 GHz) spectrometer with a TE012 cavity at 50 oK. The offset between 549 
the detection (νA) and pump (νB) frequencies was 80 MHz and the pulse sequence used 550 
was (π/2)A - τ1 – πA - (τ1+t) - πB - (τ2–t) - πA - τ2 – echo54. νA pulses were 16 ns (π/2) and 551 
32 ns (π) and separated by τ1= 380 ns, while the νB pulse was 12 ns long. The shot 552 
repetition time was set to 3 ms. The data acquired were analysed with the DeerAnalysis 553 
2016 Matlab plugin55. Time domain spectra were fitted with an exponential decay 554 
function, background-corrected and analysed by Tikhonov regularization56. The 555 
validation tool was used as previously described48, with the background starting point 556 
varying between 5% and 80% of the length of the trace in 16 steps and 50% random 557 
noise added in 50 trials for each step, resulting in 800 total trials. Finally, datasets more 558 
than 15% above the best (lowest) root-mean-square deviation (RMSD) were discarded. 559 
In silico spin labelling and distance measurements were done using the 560 
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MTSSLWizard57 PyMOL plugin, with F88 mutated to C. The “thorough search” option 561 
was used for the MTSSL rotamers and the Van der Waals restraints were set to tight. 562 
Statistical analyses. Graphs were prepared using SigmaPlot (Systat Software Inc. Ver. 563 
10. Systat Software, Point Richmond, CA, USA). Data in all assays correspond to the 564 
mean values of one to three independent experiments, each one performed in a least 565 
three replicates as mentioned in the corresponding figure legends. 566 
 567 
 568 
 569 
 570 
 571 
 572 
 573 
 574 
 575 
 576 
 577 
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Table 1. Plasmids used in this study. 827 
Plasmid Protein 
expressed 
Marker Origin of 
replication 
Source 
pASKBR2-EGFP FLAG-BR2-
TEV-EGFP-His6 
AmpR ColE1 Gialama et al.12  
pASKNTR1(D03)-
EGFP 
FLAG- 
NTR1(D03)-
TEV-EGFP-His6 
AmpR ColE1 Gialama et al.12  
pASKMscL-EGFP MscL-EGFP-His6 Amp
R ColE1 This work 
pASKBR2 BR2-His6 Amp
R ColE1 Link et al.  
pASKMscL(F88C) MscL-His6 Amp
R ColE1 This work 
pASKHtdR HtdR-His6 Amp
R ColE1 This work 
pSuptoxD DjlA-His8 Cm
R ACYC Gialama et al.12 
pSuptoxR RraA-His8 Cm
R ACYC Gialama et al.12 
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 829 
 830 
 831 
 832 
 833 
 834 
 835 
 836 
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Table 2. Membrane proteins studied in this work.  837 
Membrane 
protein 
Organism Function Number of 
TM helices 
Topology Mass 
(kDa) 
BR2 Homo sapiens Bradykinin receptor 2 
(GPCR) 
7 Nout-Cin 44.5 
NTR1(D03) Rattus 
norvegicus 
Neurotensin receptor 1 
variant D036 (GPCR) 
7 Nout-Cin 44.6 
MscL Mycobacterium 
tuberculosis 
Large conductance 
mechanosensitive 
channel 
2 Nin-Cin 16.0 
HtdR Haloterrigena 
turkmenica 
Deltarhodopsin 7 Nout-Cin 27.1 
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